What sector does Medico Remedies Limited belong to?

Medico Remedies Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of MEDICO?

As of the latest available quote, MEDICO traded at ₹37.05. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of MEDICO?

Medico Remedies Limited has a price-to-earnings (P/E) ratio of about 22.32. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of MEDICO?

The market capitalisation of Medico Remedies Limited is approximately ₹307 Cr.

Is Medico Remedies Limited profitable?

For its latest reported financial year, Medico Remedies Limited recorded a net profit margin of about 6.31%.

Does MEDICO pay a dividend?

Medico Remedies Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of MEDICO?

Medico Remedies Limited has a return on equity (ROE) of about 19.00%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of MEDICO?

Over the past 52 weeks, MEDICO has traded between a low of ₹30.22 and a high of ₹56.88.

Medico Remedies Limited

MEDICO NSE Healthcare Pharmaceuticals

₹37.05

+4.60%

Delayed · cached 15 min

Fair value analysis

MEDICO

Medico Remedies Limited

₹35.42

Close used for this calculation

₹46.41Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

59/100

Profitability19/25

Returns11/25

Balance Sheet19/25

Efficiency10/25

Growth20/25

Good

Quality radar

Consensus fair value

₹46.41

Below FV

▲ +31.0% against the close used

Model range ₹2.29 – ₹71.16

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹2.29Fair value₹46.41Bull₹71.16

FairClose

52-week traded range

52W low ₹32.7652W high ₹54.24

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Medico Remedies Limited closed at ₹35.42, 23.7% below the consensus fair value of ₹46.41 drawn from 8 valuation models.

Financial DNA score 59/100 — Good. P/E of 22.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹2.29

-93.5%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Formula

₹71.16

+100.9%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹56.41

+59.2%

EPS × 35.7x (sector P/E)

EPS=1.58, Sector P/E=35.7x

Peter Lynch (PEG)

₹34.76

-1.9%

EPS × Growth% (PEG = 1 is fair)

EPS=1.58, g=22%

EV/EBITDA

₹39.34

+11.1%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=200M

Book Value (P/B)

₹29.90

-15.6%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=9.2, ROE=19%, g=6%, r=10%

Reverse DCF

₹35.42

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 8.7% | Historical: 22%

Margin of Safety

₹32.47

-8.3%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=43.29, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer